Microdosing GLP-1s: Effectiveness, Safety, and Noom's Approach

Understanding Noom's Approach to Health

• 💡 Noom is a preventative health platform, best known for its holistic, non-diet approach to weight loss.
• 🌱 They are expanding into broader health and longevity, viewing microdosed GLP-1s as a gateway to healthy aging and vitality.
• 🎯 Noom's mission is to empower individuals to "live better longer every day," focusing on feeling better today and ensuring longevity tomorrow.

Microdosing GLP-1s vs. Standard Dosing

• 🔬 A microdose of GLP-1 at Noom is defined as 2% to 25% of the high maintenance dose, significantly lower than standard prescriptions.
• ⚖️ For semaglutide, a standard high maintenance dose is 2.4 mg, while Noom's microdose can start as low as 0.05 mg (2% of the high dose).
• 🚀 The speaker shares personal experience with microdosing tirzepatide (a triple agonist), noting it quieted "food noise" without fully suppressing appetite, unlike standard doses which can lead to nausea and severe appetite suppression.

Noom's GLP-1 Program and Safety Standards

• ✅ Noom prescribes generic, compounded, and branded GLP-1s, ensuring they are FDA-approved or compoundable by a 503A facility.
• 🔒 They emphasize using APIs from FDA-approved providers and rigorous third-party testing for compounded medications.
• 📈 Noom uses a "low and slow" titration protocol, aiming to minimize side effects and avoid rapid weight loss (more than 2-3 lbs/week) to preserve lean mass.
• 💊 The program includes a behavior change component, with 40% of monthly users actively engaging daily in tasks related to movement, resistance training, nutrition, and mental health.

Beyond Weight Loss: Systemic Benefits of GLP-1s

• ❤️ GLP-1s show potential for cardiac muscle improvement and increased cardiac blood flow.
• 📉 They can lead to a reduction in inflammation, often observed through decreased C-reactive protein levels, which may resolve issues like joint pain.
• 🧠 There's ongoing research into potential impacts on brain health, including early-stage Alzheimer's, and a notable effect on the brain's reward center, decreasing cravings (e.g., for alcohol) while increasing liking for food.
• ⚖️ Studies suggest GLP-1s may improve fertility and PCOS outcomes.

Tracking Effectiveness and Future Outlook

• 📊 Noom integrates easy at-home lab testing using a Tasso device, tracking biomarkers like A1C, triglycerides, C-reactive protein, and testosterone.
• 📈 This allows regular monitoring of health transformation, providing data on the impact of microdosed GLP-1s and habit changes.
• 🗣️ Noom is also advocating for lower drug prices by proposing that 503b pharmacies be allowed to compound medications when prices are excessively high, effectively treating high cost as a form of shortage.